➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Express Scripts
Colorcon
Merck
McKinsey

Last Updated: July 30, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 211835


Email this page to a colleague

« Back to Dashboard

NDA 211835 describes APREPITANT, which is a drug marketed by Glenmark Pharms Sa, Sandoz, and Torrent, and is included in three NDAs. It is available from three suppliers. Additional details are available on the APREPITANT profile page.

The generic ingredient in APREPITANT is aprepitant. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aprepitant profile page.
Summary for 211835
Tradename:APREPITANT
Applicant:Torrent
Ingredient:aprepitant
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 211835
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
APREPITANT aprepitant CAPSULE;ORAL 211835 ANDA Torrent Pharmaceuticals Limited 13668-591 13668-591-81 1 BLISTER PACK in 1 CARTON (13668-591-81) > 1 CAPSULE in 1 BLISTER PACK (13668-591-80)
APREPITANT aprepitant CAPSULE;ORAL 211835 ANDA Torrent Pharmaceuticals Limited 13668-591 13668-591-82 5 BLISTER PACK in 1 CARTON (13668-591-82) > 1 CAPSULE in 1 BLISTER PACK (13668-591-80)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength40MG
Approval Date:Oct 21, 2020TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength80MG
Approval Date:Oct 21, 2020TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength125MG
Approval Date:Oct 21, 2020TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKesson
Johnson and Johnson
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.